OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
DYOBY55

Dyo Boya Fabrikalari Sanayi Ve Ticaret AS

Commodity ChemicalsVerified

Dyo Boya Fabrikalari operates with a debt-to-equity ratio of 0.88, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.98, suggesting limited short-term liquidity cushion. Free cash flow is negative at -118.45 million TRY, and operating cash flow is also negative at -213.05 million TRY, reflecting ongoing cash outflows from operations. Profitability metrics show a return on equity of -1.56% and a return on assets of -0.48%, both significantly below the industry median for commodity chemicals, which typically exhibit positive returns in stable market conditions. The company's net income is negative at -64.69 million TRY, and operating income is 242.30 million TRY, indicating a narrowing margin between operating and net performance. Geographic and segment exposure is not explicitly detailed in the available data, but the company's revenue is concentrated in Turkey, as no international operations are disclosed in the financial snapshot. The lack of geographic diversification may increase exposure to local economic and regulatory risks. The company's growth trajectory is uncertain, with no forward-looking revenue guidance provided in the available data. Historical revenue of 3.32 billion TRY does not include year-over-year comparisons, making it difficult to assess growth or contraction. The capital expenditure of -148.16 million TRY suggests ongoing investment in operations, but the impact on future revenue is unclear without further context. Risk factors include a negative net cash position after subtracting total debt, which raises concerns about liquidity and financial flexibility. The dilution risk is assessed as low, with no dilution expected in the near term, as shares outstanding remain unchanged between basic and diluted measures. However, the company's negative net income and cash outflows may pressure future capital structure decisions. Recent events, including filings and transcripts, are not detailed in the available data, limiting insight into management commentary or strategic shifts.

30-day price · DYOBY+5.14 (+40.2%)
Low$12.73High$22.80Close$17.93As of11 May, 00:00 UTC
Profile
CompanyDyo Boya Fabrikalari Sanayi Ve Ticaret AS
TickerDYOBY.IS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Dyo Boya Fabrikalari Sanayi Ve Ticaret AS is a Turkish chemicals company that produces and sells commodity chemicals, primarily serving industrial and consumer markets.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

Dyo Boya Fabrikalari operates with a debt-to-equity ratio of 0.88, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.98, suggesting limited short-term liquidity cushion. Free cash flow is negative at -118.45 million TRY, and operating cash flow is also negative at -213.05 million TRY, reflecting ongoing cash outflows from operations. Profitability metrics show a return on equity of -1.56% and a return on assets of -0.48%, both significantly below the industry median for commodity chemicals, which typically exhibit positive returns in stable market conditions. The company's net income is negative at -64.69 million TRY, and operating income is 242.30 million TRY, indicating a narrowing margin between operating and net performance. Geographic and segment exposure is not explicitly detailed in the available data, but the company's revenue is concentrated in Turkey, as no international operations are disclosed in the financial snapshot. The lack of geographic diversification may increase exposure to local economic and regulatory risks. The company's growth trajectory is uncertain, with no forward-looking revenue guidance provided in the available data. Historical revenue of 3.32 billion TRY does not include year-over-year comparisons, making it difficult to assess growth or contraction. The capital expenditure of -148.16 million TRY suggests ongoing investment in operations, but the impact on future revenue is unclear without further context. Risk factors include a negative net cash position after subtracting total debt, which raises concerns about liquidity and financial flexibility. The dilution risk is assessed as low, with no dilution expected in the near term, as shares outstanding remain unchanged between basic and diluted measures. However, the company's negative net income and cash outflows may pressure future capital structure decisions. Recent events, including filings and transcripts, are not detailed in the available data, limiting insight into management commentary or strategic shifts.
Key takeaways
  • Dyo Boya Fabrikalari has a moderate debt load and limited liquidity, with a current ratio of 0.98.
  • The company is unprofitable, with a negative return on equity of -1.56% and a net loss of 64.69 million TRY.
  • Free cash flow and operating cash flow are both negative, indicating ongoing cash outflows.
  • The company's financial position is constrained by a negative net cash position after debt.
  • No international operations are disclosed, suggesting high geographic concentration risk.
  • Dilution risk is low, but financial performance may require capital structure adjustments.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyTRY
Revenue$3.32B
Gross profit$888.7M
Operating income$242.3M
Net income-$64.7M
R&D
SG&A
D&A
SBC
Operating cash flow-$213.1M
CapEx-$148.2M
Free cash flow-$118.5M
Total assets$13.60B
Total liabilities$9.47B
Total equity$4.13B
Cash & equivalents$526.3M
Long-term debt$3.65B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$2.30B$63.8M-$720.0k-$28.9M
FY-3$8.16B-$46.0M$354.4M-$756.4M
FY-2$12.31B$253.6M$471.4M-$1.37B
FY-1$14.03B$898.0M-$221.2M$38.1M
FY0$10.22B$405.2M-$427.3M-$408.9M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$2.37B$653.1M$12.6M
FY-3$9.24B$3.54B$253.1M
FY-2$15.02B$5.23B$438.3M
FY-1$19.56B$7.83B$415.0M
FY0$18.30B$7.37B$72.6M
PeriodOCFCapExFCFSBC
FY-4$145.1M-$61.8M-$28.9M
FY-3-$236.1M-$1.31B-$756.4M
FY-2$987.4M-$1.94B-$1.37B
FY-1$661.8M-$219.5M$38.1M
FY0$1.92B-$474.8M-$408.9M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$3.32B$242.3M-$64.7M-$118.5M
FQ-6$3.26B-$45.2M$205.3M$160.0M
FQ-5$2.94B$332.1M-$106.9M-$183.0M
FQ-4$3.81B$338.4M-$261.3M$173.2M
FQ-3$2.42B$185.2M$9.8M-$16.7M
FQ-2$1.70B-$333.8M-$505.0M-$465.9M
FQ-1$2.68B$476.4M$116.9M-$46.9M
FQ0$2.94B$76.6M-$12.5M$157.2M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$13.60B$4.13B$526.3M
FQ-6$12.96B$4.65B$125.5M
FQ-5$13.36B$4.98B$111.7M
FQ-4$19.56B$7.83B$415.0M
FQ-3$18.04B$6.65B$125.7M
FQ-2$17.16B$6.50B$88.2M
FQ-1$17.90B$7.11B$116.9M
FQ0$18.30B$7.37B$72.6M
PeriodOCFCapExFCFSBC
FQ-7-$213.1M-$148.2M-$118.5M
FQ-6$217.6M-$340.2M$160.0M
FQ-5$213.4M-$516.1M-$183.0M
FQ-4$661.8M-$219.5M$173.2M
FQ-3$349.8M-$119.4M-$16.7M
FQ-2$1.18B-$190.7M-$465.9M
FQ-1$1.93B-$493.4M-$46.9M
FQ0$1.92B-$474.8M$157.2M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$4.13B
Net cash-$3.13B
Current ratio1.0
Debt/Equity0.9
ROA-0.5%
ROE-1.6%
Cash conversion3.3%
CapEx/Revenue-4.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricDYOBYActivity
Op margin7.3%5.5% medp25 -0.0% · p75 10.8%above median
Net margin-2.0%4.1% medp25 0.1% · p75 8.8%bottom quartile
Gross margin26.8%20.5% medp25 12.4% · p75 29.7%above median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-4.5%-6.2% medp25 -13.4% · p75 -2.6%above median
Debt / equity88.0%37.1% medp25 10.3% · p75 82.0%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 10:36 UTC#da46205a
Market quoteclose TRY 17.34 · shares 0.30B diluted
no public URL
2026-05-10 10:36 UTC#4332a771
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 19:43 UTCJob: 458b6817